levodopa has been researched along with Adipocere in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, M; Cenci, MA; Iderberg, H; Lees, AJ; Lindgren, HS; O'Sullivan, SS; Rylander, D; Williams, DR | 1 |
| Aalto, S; Bergman, J; Brück, A; Marttila, R; Rauhala, E; Rinne, JO | 1 |
| Calon, F; Di Paolo, T; Grégoire, L; Hornykiewicz, O; Rajput, A; Rajput, AH; Samadi, P | 1 |
| Holton, JL; Johnson, M; Lees, AJ; O'Sullivan, SS; Perry, EK; Revesz, T; Williams, DR | 1 |
| Barroso-Chinea, P; Berthet, A; Bezard, E; Canron, MH; Charron, G; Delalande, F; Doudnikoff, E; Giros, B; Goumon, Y; Laux, A; Li, Q; Nosten-Bertrand, M; Porras, G; Qin, C; Van Dorsselaer, A; Vital, A | 1 |
| Bédard, PJ; Calon, F; Di Paolo, T; Hornykiewicz, O; Morissette, M; Rajput, AH | 1 |
| Bédard, PJ; Berthiaume, L; Calon, F; Di Paolo, T; Hadj-Tahar, A; Julien, C; Julien, P; Rajput, AH | 1 |
| Koskinen, V; Lönnberg, P; Rinne, UK | 1 |
| Kehr, W; Thiede, HM | 1 |
| Riederer, P; Wuketich, S | 1 |
10 other study(ies) available for levodopa and Adipocere
| Article | Year |
|---|---|
Putaminal upregulation of FosB/ΔFosB-like immunoreactivity in Parkinson's disease patients with dyskinesia.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Antiparkinson Agents; Autoradiography; Basal Ganglia; Dopamine Plasma Membrane Transport Proteins; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Neurons; Parkinson Disease; Postmortem Changes; Proto-Oncogene Proteins c-fos; Putamen; Up-Regulation | 2011 |
A follow-up study on 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease shows nonlinear progression in the putamen.
Topics: Aged; Brain Mapping; Disease Progression; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Nonlinear Dynamics; Parkinson Disease; Positron-Emission Tomography; Postmortem Changes; Putamen; Time Factors | 2009 |
Metabotropic glutamate receptor II in the brains of Parkinsonian patients.
Topics: Aged; Aged, 80 and over; Amino Acids; Antiparkinson Agents; Brain; Cocaine; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Female; Humans; Iodine Radioisotopes; Levodopa; Male; Parkinsonian Disorders; Postmortem Changes; Radioligand Assay; Receptors, Metabotropic Glutamate; Tritium; Xanthenes | 2009 |
The effect of drug treatment on neurogenesis in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Cell Differentiation; Cerebral Ventricles; Female; Gene Expression Regulation; Humans; Levodopa; Male; Middle Aged; Nerve Tissue Proteins; Neural Stem Cells; Neurogenesis; Parkinson Disease; Postmortem Changes; Regression Analysis; Retrospective Studies; RNA-Binding Proteins | 2011 |
Endogenous morphine-like compound immunoreactivity increases in parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; alpha-Methyltyrosine; Analysis of Variance; Animals; Brain; Choline O-Acetyltransferase; Chromatography, High Pressure Liquid; Dendrites; Disease Models, Animal; Dopamine; Dopamine Agents; Dopamine and cAMP-Regulated Phosphoprotein 32; Dopamine Plasma Membrane Transport Proteins; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Female; Functional Laterality; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Glutamate Decarboxylase; Humans; Levodopa; Macaca fascicularis; Male; Medial Forebrain Bundle; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Immunoelectron; Middle Aged; Nerve Growth Factors; Organic Chemicals; Oxidopamine; Parkinsonian Disorders; Postmortem Changes; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Tandem Mass Spectrometry | 2011 |
Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Autoradiography; Brain; Case-Control Studies; Dopamine; Dyskinesia, Drug-Induced; Female; Globus Pallidus; Humans; Levodopa; Male; Parkinson Disease; Postmortem Changes; Receptors, GABA; Receptors, GABA-A; Receptors, GABA-B | 2003 |
Postmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys.
Topics: Aged; Aged, 80 and over; Animals; Arachidonic Acid; Cerebral Cortex; Chromatography, Gas; Dietary Fats; Disease Models, Animal; Docosahexaenoic Acids; Dopamine Agents; Dyskinesia, Drug-Induced; Fatty Acids; Fatty Acids, Unsaturated; Female; Humans; Levodopa; Lipid Metabolism; Macaca fascicularis; Male; Neurons; Parkinson Disease; Parkinsonian Disorders; Postmortem Changes; Species Specificity | 2006 |
Dopamine receptors in the Parkinsonian brain.
Topics: Aged; Antipsychotic Agents; Brain; Caudate Nucleus; Female; Humans; Kinetics; Levodopa; Male; Parkinson Disease; Postmortem Changes; Putamen; Receptors, Dopamine; Spiperone | 1981 |
Catecholamine metabolism in rat brain. The role of neutral and acidic catechol metabolites.
Topics: Animals; Brain; Catecholamines; Catechols; Dopamine; Levodopa; Male; Monoamine Oxidase Inhibitors; Norepinephrine; Postmortem Changes; Rats; Rats, Inbred Strains; Reserpine; Time Factors | 1981 |
Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysis.
Topics: Age Factors; Aged; Biogenic Amines; Brain Chemistry; Circadian Rhythm; Dopamine; Female; Humans; Levodopa; Male; Middle Aged; Norepinephrine; Parkinson Disease; Postmortem Changes; Serotonin; Temperature; Time Factors | 1976 |